Description: VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
Home Page: www.vbivaccines.com
160 Second Street
Cambridge,
MA
02142
United States
Phone:
617 830 3031
Officers
| Name | Title |
|---|---|
| Mr. Jeffery R. Baxter FCMA | President, CEO & Director |
| Dr. David Evander Anderson Ph.D. | Chief Scientific Officer |
| Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. | Chief Medical Officer |
| Ms. Nicole Anderson | Director of Corporate Communications & Investor Relations |
| Ms. Athena Kartsaklis | Senior VP of Finance, Chief Compliance Officer & Principal Financial Officer |
| Mr. Avi Mazaltov | Global Head of Manufacturing & GM of SciVac |
| Mr. Misha Nossov | Senior VP of Global Commercial Supply Strategy & Head of Europe |
| Mr. T. Adam Buckley B.Sc., MBA | Senior Vice President of Business Development |
| Mr. John Robert Dillman | Chief Commercial Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 131 |